Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
SafeinHome Secures $25M Series D Funding Led by SEMCAP Health
Series DVenture Capital

SafeinHome Secures $25M Series D Funding Led by SEMCAP Health

•December 12, 2025
•Dec 12, 2025
0

Participants

SafeinHome

SafeinHome

company

SEMCAP

SEMCAP

investor

Why It Matters

The infusion strengthens SafeinHome’s ability to scale its remote support technology, positioning it to capture growing demand in the I/DD care market. It also signals broader investor appetite for digital health solutions that improve accessibility and outcomes.

Key Takeaways

  • •SafeinHome raises $25M Series D.
  • •Total funding now $67M.
  • •SEMCAP Health leads round.
  • •Funding fuels remote support tech expansion.
  • •Positions company as I/DD services leader.

Pulse Analysis

The remote support sector for individuals with intellectual and developmental disabilities (I/DD) is undergoing a seismic shift, driven by advances in telehealth, AI‑assisted monitoring, and a heightened focus on person‑centered care. Providers that can deliver high‑quality services at scale are poised to meet the rising demand from families and state agencies seeking cost‑effective alternatives to traditional in‑person models. SafeinHome’s platform, which integrates real‑time data analytics with customized care plans, exemplifies this new paradigm, offering measurable outcomes while reducing caregiver burden.

The $25 million Series D, led by SEMCAP Health, provides SafeinHome with the runway to deepen its technology stack and expand geographically. Capital will be allocated to enhance AI‑driven risk detection, broaden the device ecosystem, and accelerate hiring of clinical specialists to support a growing client base. Existing investors’ continued participation signals confidence in the company’s execution track record, while SEMCAP’s healthcare expertise is expected to open doors to strategic partnerships with insurers and Medicaid programs, further embedding SafeinHome’s services into public health frameworks.

Industry observers view this funding milestone as a bellwether for the broader digital health market, where remote care solutions are increasingly viewed as essential infrastructure. Competitors will likely intensify R&D spending to match SafeinHome’s innovation pace, potentially spurring consolidation as larger health systems seek to integrate specialized remote support capabilities. For stakeholders, the round highlights a clear trajectory: robust capital inflows, accelerated technology adoption, and a reshaped competitive landscape that favors firms delivering scalable, outcome‑focused remote care for the I/DD community.

Deal Summary

SafeinHome announced the first close of its targeted $25 million Series D round, bringing its total funding to $67 million. The round was led by SEMCAP Health, with participation from existing investors, bolstering SafeinHome’s remote support services for individuals with intellectual and developmental disabilities.

0

Comments

Want to join the conversation?

Loading comments...